FDA Inspection 1319104 — LifeStream Blood Bank

LifeStream Blood Bank — FEI 2077725

The FDA completed an inspection of LifeStream Blood Bank on May 6, 2026 in Riverside, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 6, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Riverside, CA (United States)